30 Programs
-
The New Understanding of Toxicities Associated with Chimeric Antigen Receptor (CAR) T-Cell Therapy
-
-
M
-
M
-
-
M
-
M
-
-
Current and Future Management of HER2-Altered Non-Small Cell Lung Cancer
-
-
J
-
J
-
-
J
-
J
-
-
The Role of Oral Selective Estrogen Receptor Degraders in the Management of ER-Positive Metastatic Breast Cancer
-
-
P
-
P
-
-
P
-
P
-
-
Key Presentations from the 2025 ASCO Annual Meeting and the EHA 2025 Congress — Acute Myeloid Leukemia Edition
-
-
E
-
E
-
-
E
-
E
-